Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Accelerating the Path To Scale for Injectable PrEP in Malawi: An Implementation Evaluation

NCT06319105 is registered in ClinicalTrials.gov with Georgetown University as lead sponsor.

NCT NCT06319105
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06319105 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Accelerating the Path To Scale for Injectable PrEP in Malawi: An Implementation Evaluation
Lead sponsor
Georgetown University
Phase
Observational
Overall status
Unknown status
Start date
March 26, 2024
Completion date
April 1, 2026
Enrollment
9,900 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

long-acting injectable cabotegravir for prep, oral pre-exposure prophylaxis (prep)